Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Huang

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
Frontiers in Immunology|July 11, 2025
Nanolipoprotein particle (NLP) vaccine confers protection against <i>Yersinia pestis</i> aerosol challenge in a BALB/c mouse modelSergei S Biryukov, Amy Rasley, Michael L Davies, et al.
Frontiers in Immunology|July 19, 2023
Third dose of BNT162b2 improves immune response in liver transplant recipients to ancestral strain but not Omicron BA.1 and XBBZi Wei Chang, Yun Shan Goh, Angeline Rouers, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 31, 2023
Pseudomonasaeruginosa antimicrobial susceptibility profiles, resistance mechanisms and international clonal lineages: update from ESGARS-ESCMID/ISARPAE GroupAntonio Oliver, Estrella Rojo-Molinero, Jorge Arca-Suarez, et al.
Hepatology International|September 7, 2022
Effectiveness of entecavir vs tenofovir disoproxil fumarate for functional cure of chronic hepatitis B in an international cohortYao-Chun Hsu, Dae Won Jun, Cheng-Yuan Peng, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
Frontiers in Immunology|July 11, 2025
Nanolipoprotein particle (NLP) vaccine confers protection against <i>Yersinia pestis</i> aerosol challenge in a BALB/c mouse modelSergei S Biryukov, Amy Rasley, Michael L Davies, et al.
Frontiers in Immunology|July 19, 2023
Third dose of BNT162b2 improves immune response in liver transplant recipients to ancestral strain but not Omicron BA.1 and XBBZi Wei Chang, Yun Shan Goh, Angeline Rouers, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 31, 2023
Pseudomonasaeruginosa antimicrobial susceptibility profiles, resistance mechanisms and international clonal lineages: update from ESGARS-ESCMID/ISARPAE GroupAntonio Oliver, Estrella Rojo-Molinero, Jorge Arca-Suarez, et al.
Hepatology International|September 7, 2022
Effectiveness of entecavir vs tenofovir disoproxil fumarate for functional cure of chronic hepatitis B in an international cohortYao-Chun Hsu, Dae Won Jun, Cheng-Yuan Peng, et al.
Pageof 7